Jun 30, 2013

Neurocrine Biosciences Q2 2013 Earnings Report

Total Revenue
$730K
Previous year: $10.6M
-93.1%
EPS
-$0.18
Previous year: -$0.01
+1700.0%
Gross Profit
$730K
Previous year: $10.6M
-93.1%
Cash and Equivalents
$44.3M
Previous year: $42M
+5.5%
Free Cash Flow
-$10.1M
Previous year: -$7.07M
+43.2%
Total Assets
$175M
Previous year: $202M
-13.5%

Neurocrine Biosciences

Neurocrine Biosciences